Sijia Cai

Davis Polk advised Morgan Stanley in connection with its SEC-registered global offering of $6 billion aggregate principal amount of senior notes, consisting of $2.5 billion floating-rate…

Davis Polk advised XP Inc. on its $2.25 billion initial public offering of 83,387,237 Class A common shares, consisting of 42,553,192 shares sold by XP and 40,834,045 shares sold by…

Davis Polk advised Banco Santander S.A. in connection with the establishment of its $15 billion U.S. commercial paper program. The commercial paper notes under the program will be offered…

Davis Polk advised Morgan Stanley in connection with its $500 million SEC-registered offering of 20,000,000 depositary shares, each representing a 1/1,000th interest in a share of its 4.875…

Davis Polk advised JHSF Participações S.A. in connection with its equity offering of 108,000,000 common shares for an aggregate amount of R$513 million (approximately $122 million). The…

Davis Polk advised the underwriters in connection with a $38.4 million initial public offering of common stock of RAPT Therapeutics, Inc. RAPT Therapeutics’ common stock is listed on…

Davis Polk advised Murphy USA Inc. in connection with an SEC-registered offering of $500 million aggregate principal amount of 4.750% senior notes due 2029 and a tender offer for any and…

Davis Polk advised Afya Limited on its $300.3 million initial public offering of 15,805,841 Class A common shares, which includes the full exercise of the underwriters’ option to…

Davis Polk advised Morgan Stanley in connection with its SEC-registered global offering of $2 billion aggregate principal amount of fixed-to-floating-rate senior notes due 2025. During the…

Davis Polk advised Banco Santander, S.A. in connection with its SEC-registered offering of $1.5 billion aggregate principal amount of 2.706% senior preferred fixed-rate notes due 2024 and …